Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 8 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 8 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 16 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 16 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
candpress tafla 16 mg
teva b.v.* - candesartanum cílexetíl - tafla - 16 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
candpress tafla 8 mg
teva b.v.* - candesartanum cílexetíl - tafla - 8 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
candpress comp tafla 16 mg/12,5 mg
teva b.v.* - candesartanum cílexetíl; hydrochlorothiazide - tafla - 16 mg/12,5 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 32 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 32 mg
Uniunea Europeană -
islandeză -
EMA (European Medicines Agency)
edarbi
takeda pharma a/s - azilsartan medoxomil - háþrýstingur - lyf sem hafa áhrif á renín-angíótensín kerfið - edarbi er ætlað til meðferðar við nauðsynlegum háþrýstingi hjá fullorðnum.
Uniunea Europeană -
islandeză -
EMA (European Medicines Agency)
rasilez
noden pharma dac - aliskiren - háþrýstingur - lyf sem hafa áhrif á renín-angíótensín kerfið - meðferð við nauðsynlegum háþrýstingi.
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
amiloride/hct alvogen (diuramin) tafla 5/50 mg
alvogen ehf. - amiloridum hýdróklóríð; hydrochlorothiazidum inn - tafla - 5/50 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
amiloride/hct alvogen (diuramin mite) tafla 2,5/25 mg
alvogen ehf. - amiloridum hýdróklóríð; hydrochlorothiazidum inn - tafla - 2,5/25 mg